T2 Biosystems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No....

T2 Biosystems (NASDAQ:TTOO – Get Free Report) had its price target decreased by investment analysts at Canaccord Genuity Group from $12.00 to $3.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “hold” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would indicate a potential upside of […]

T2 Biosystems (NASDAQ:TTOO – Get Free Report) had its target price dropped by equities researchers at Canaccord Genuity Group from $12.00 to $3.00 in a research note issued on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]

T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript February 15, 2024 T2 Biosystems, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone. And welcome to the T2 Biosystems Preliminary Fourth Quarter and Full Year 2023 Results […]

T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 329,800 shares, a growth of 18.6% from the December 31st total of 278,000 shares. Approximately 8.2% of the company’s shares are sold short. Based on an […]